Literature DB >> 15091293

Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation.

Steven H Lamm1, Arnold Engel, Michael B Kruse, Manning Feinleib, Daniel M Byrd, Shenghan Lai, Richard Wilson.   

Abstract

This study analyzes the relationship between arsenic exposure through drinking water and bladder cancer mortality. The county-specific white male bladder cancer mortality data (1950-1979) and county-specific groundwater arsenic concentration data were obtained for 133 U.S. counties known to be exclusively dependent on groundwater for their public drinking water supply. No arsenic-related increase in bladder cancer mortality was found over the exposure range of 3 to 60 microg/L using stratified analysis and regression analyses (both unweighted and weighted by county population and using both mean and median arsenic concentrations). These results, which provide a direct estimate of arsenic-related cancer risk for U.S. residents, exclude the National Research Council's 2001 risk estimate that was based on Southwest Taiwan data and required adjusting for differences between the body mass and water consumption rates of U.S. and Taiwanese residents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15091293     DOI: 10.1097/01.jom.0000116801.67556.8f

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  20 in total

1.  Changing the Risk Paradigms Can be Good for Our Health: J-Shaped, Linear and Threshold Dose-Response Models.

Authors:  P F Ricci; S R Straja; A L Cox
Journal:  Dose Response       Date:  2011-09-29       Impact factor: 2.658

2.  Relationships between arsenic concentrations in drinking water and lung and bladder cancer incidence in U.S. counties.

Authors:  William M Mendez; Sorina Eftim; Jonathan Cohen; Isaac Warren; John Cowden; Janice S Lee; Reeder Sams
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-11-30       Impact factor: 5.563

3.  p53-Based Strategy for Protection of Bone Marrow From Y-90 Ibritumomab Tiuxetan.

Authors:  Hang Su; Suthakar Ganapathy; Xiaolei Li; Zhi-Min Yuan; Chul S Ha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-08       Impact factor: 7.038

4.  Further evidence against a direct genotoxic mode of action for arsenic-induced cancer.

Authors:  Catherine B Klein; Joanna Leszczynska; Christina Hickey; Toby G Rossman
Journal:  Toxicol Appl Pharmacol       Date:  2007-01-08       Impact factor: 4.219

5.  Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

Authors:  Jaymie R Meliker; Melissa J Slotnick; Gillian A AvRuskin; David Schottenfeld; Geoffrey M Jacquez; Mark L Wilson; Pierre Goovaerts; Alfred Franzblau; Jerome O Nriagu
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

6.  Nrf2 protects against As(III)-induced damage in mouse liver and bladder.

Authors:  Tao Jiang; Zheping Huang; Jefferson Y Chan; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2009-06-16       Impact factor: 4.219

7.  Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction.

Authors:  Xiao-Jun Wang; Zheng Sun; Weimin Chen; Yanjie Li; Nicole F Villeneuve; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2008-03-12       Impact factor: 4.219

8.  Arsenic levels in ground water and cancer incidence in Idaho: an ecologic study.

Authors:  Yueh-Ying Han; Joel L Weissfeld; Devra L Davis; Evelyn O Talbott
Journal:  Int Arch Occup Environ Health       Date:  2008-10-22       Impact factor: 3.015

9.  Mapping dynamic histone modification patterns during arsenic-induced malignant transformation of human bladder cells.

Authors:  Yichen Ge; Jinqiu Zhu; Xue Wang; Nina Zheng; Chengjian Tu; Jun Qu; Xuefeng Ren
Journal:  Toxicol Appl Pharmacol       Date:  2018-06-30       Impact factor: 4.219

10.  Lung cancer in a U.S. population with low to moderate arsenic exposure.

Authors:  Julia E Heck; Angeline S Andrew; Tracy Onega; James R Rigas; Brian P Jackson; Margaret R Karagas; Eric J Duell
Journal:  Environ Health Perspect       Date:  2009-07-02       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.